Gelclair Bioadherent Oral Gel


The death rate from cancer has declined steadily over the past 20 years due in part to advances in early detection and innovations in treatment options, however, the fact remains that patients can be left having to manage a variety of troubling side effects and complications.

One such side effect, Oral Mucositis, is reported to be one of the most debilitating.
Join us for a discussion on an innovative solution in supportive cancer care as we visit with Annette Quinn, Program Manager of Radiation Oncology at the University of Pittsburgh Cancer Center and TBD, a patient suffering from Oral Mucositis. GELCLAIR is indicated for the treatment of oral mucositis and studies have shown it starts soothing pain rapidly, decreases oral pathogen load, and helps reduce OM severity.